What is TECH stock price today?

Visit our real-time dashboard for the current TECH stock price and live market data.

Is TECH stock going up or down today?

TECH stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy TECH stock now?

The decision to buy TECH depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is TECH a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for TECH based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is TECH stock overvalued or undervalued?

TECH currently trades at a P/E ratio of 65.23, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if TECH is fairly priced.

What is TECH's P/E ratio?

TECH has a price-to-earnings (P/E) ratio of 65.23, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is TECH's market cap?

TECH (Bio-Techne Corp) has a market capitalization of $8.49 billion, making it a small-cap stock.

What is TECH's price to book ratio?

Price-to-book ratio for TECH is available on our dashboard along with other valuation metrics.

Does TECH pay dividends?

Yes, TECH pays dividends with a current yield of 0.62%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is TECH's dividend yield?

TECH's dividend yield is 0.62%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is TECH stock a good long-term investment?

TECH's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is TECH's revenue growth rate?

Revenue growth data for TECH is available on our dashboard with detailed financial statement analysis.

Profitability metrics for TECH are available on our dashboard with complete income statement analysis.

What are the risks of investing in TECH?

Key risks for TECH include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does TECH compare to its competitors?

Compare TECH to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize TECH's performance and positioning.

What is TECH's stock price target for 2026?

Visit our prediction page for AI-powered price targets for TECH with bull, base, and bear case scenarios.

What do analysts say about TECH?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for TECH. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is TECH's next earnings report?

TECH reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

TECH - Bio-Techne Corp

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Bio-Techne Corp

Bio-Techne Corp (TECH) common stock

Price Chart

Loading chart...

TECH Key Statistics

Market Cap

$8.49B

P/E Ratio

65.23

Dividend Yield

0.62%

How TECH Compares to Peers

TECH trades at a premium valuation vs peers (highest P/E)

TECH is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
TECH(This stock)	$8.49B	65.2	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 14, 2026 at 6:16 PM EDT

Ready to invest in TECH?

Commission-free trading available. Affiliate links.

TECH Lician Score

10% confidence

5.0/10

Neutral

TECH has a Lician Score of 5/10 (Average). Areas of concern: Growth.

value

5.0

growth

3.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates TECHacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

TECH Financial Snowflake

5-axis analysis across key investment dimensions

4.6/10

Neutral

5.0

Value

Valuation vs. sector peers

3.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for TECH

Dashboard

Enter a ticker to analyze